AACR Cancer Progress Report 2021
Discovery science is expanding our understanding of many genetic mutations that drive cancer development and led to the development of new molecularly targeted therapeutics.
Learn More
Discovery science is expanding our understanding of many genetic mutations that drive cancer development and led to the development of new molecularly targeted therapeutics.
Learn More
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn More
Learn about cancer researchers and physician-scientists like Fellow of the AACR Academy Charles L. Sawyers, MD, a leader in the development of targeted therapies, who are driving progress against cancer.
Learn More
More than 76,000 people in the United States are expected to be diagnosed with kidney cancer this year. Learn about this type of cancer including the treatment options.
Learn More
AACR Project GENIE is a publicly accessible international cancer registry of real-world data assembled through data sharing between 19 of the leading cancer centers in the world.
Learn More
How much fiber is too much? Read practical knowledge for articles with useful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.
Read More
Whether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate Now
Download the Call for Abstracts for the AACR Annual Meeting 2022, April 8-13, New Orleans, Louisiana.
The American Association for Cancer Research’s annual AACR Cancer Progress Report highlights research-driven advances against cancer.
Learn MoreThe AACR and our more than 49,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreAACR President David A. Tuveson, MD, PhD, FAACR, discusses a year in advances against cancer and his excitement about the AACR’s role in “charting that next phase” of progress.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2020, to July 31, 2021
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2018
Learn MoreYour donation to the American Association for Cancer Research helps our more than 49,000 members worldwide drive progress against cancer.
Donate Now